LARIAGO

Lariago 40mg Injection is a medication designed to combat parasitic infections, particularly malaria. Its mechanism of action involves the elimination of the parasite responsible for malaria, thereby preventing the progression of the illness. The injection should only be administered by a qualified healthcare professional, and self-injection is not advised. To minimize the risk of mosquito bites, individuals are encouraged to apply insect repellents on exposed skin and use sprays to eliminate any mosquitoes that may have entered indoor spaces despite protective measures. It is also advisable to wear light-colored clothing that provides adequate coverage while outdoors, especially during evening hours when mosquitoes are most active. Possible side effects of this medication may include feelings of weakness, vomiting, rashes, and itching. Additional reactions such as abdominal pain, diarrhea, decreased appetite, and nausea can occur. Patients may also experience localized reactions at the injection site, including pain, swelling, or redness. For any side effects that persist or cause concern, it is important to seek medical advice. Patients with diabetes should inform their healthcare provider, as this medication can affect blood sugar levels, necessitating regular monitoring. Regular eye check-ups are recommended as vision changes may occur during treatment. Long-term users may require periodic assessments of their blood cell counts.